Search research articles
Contact Us
Filters
Showing results (211-220 of 465) with videos related to
Page
of 47
Sort By:
Dermatology (Basel, Switzerland)
|
January 1, 1997
Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2
P Wolkenstein, H Benchikhi, J Zeller, et al.
The British Journal of Dermatology
|
January 17, 2007
Infliximab-induced acne: report of two cases
E Bassi, F Poli, A Charachon, et al.
Annales De Dermatologie Et De Venereologie
|
June 9, 2006
[Fatal epidermoid carcinoma in hidradenitis suppurativa following treatment with infliximab]
E Maalouf, O Faye, F Poli, et al.
Lancet (London, England)
|
November 30, 1985
Reporting adverse drug reactions
J C Roujeau, J C Guillaume, J Revuz, et al.
Lancet (London, England)
|
April 26, 1997
Benefit-risk assessment of acne therapies
N Bénéton, H Bocquet, A Cosnes, et al.
Archives of Dermatology
|
April 1, 1988
Papillon-Lefèvre syndrome. Ultrastructural study and successful treatment with acitretin
V Nazzaro, C Blanchet-Bardon, C Mimoz, et al.
Arthritis and Rheumatism
|
April 1, 1995
Toxic epidermal necrolysis after sulfasalazine treatment of mild psoriatic arthritis: warning on the use of sulfasalazine for a new indication
D Jullien, P Wolkenstein, E Roupie, et al.
Annales De Dermatologie Et De Venereologie
|
January 1, 1989
[Angiomatoid histiocytofibroma]
L Verne, T Clerici, J C Guillaume, et al.
Journal of the American Academy of Dermatology
|
April 1, 1992
Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus
P Saiag, E Caumes, O Chosidow, et al.
The British Journal of Dermatology
|
March 1, 1994
Increased serum and blister fluid levels of creatine kinase in patients with toxic epidermal necrolysis
F Caux, O Chosidow, C Philippon, et al.
Page
of 47
Search research articles
Search
Showing results (211-220 of 465) with videos related to
Sort By:
Page
of 47
Dermatology (Basel, Switzerland)
|
January 1, 1997
Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2
P Wolkenstein, H Benchikhi, J Zeller, et al.
The British Journal of Dermatology
|
January 17, 2007
Infliximab-induced acne: report of two cases
E Bassi, F Poli, A Charachon, et al.
Annales De Dermatologie Et De Venereologie
|
June 9, 2006
[Fatal epidermoid carcinoma in hidradenitis suppurativa following treatment with infliximab]
E Maalouf, O Faye, F Poli, et al.
Lancet (London, England)
|
November 30, 1985
Reporting adverse drug reactions
J C Roujeau, J C Guillaume, J Revuz, et al.
Lancet (London, England)
|
April 26, 1997
Benefit-risk assessment of acne therapies
N Bénéton, H Bocquet, A Cosnes, et al.
Archives of Dermatology
|
April 1, 1988
Papillon-Lefèvre syndrome. Ultrastructural study and successful treatment with acitretin
V Nazzaro, C Blanchet-Bardon, C Mimoz, et al.
Arthritis and Rheumatism
|
April 1, 1995
Toxic epidermal necrolysis after sulfasalazine treatment of mild psoriatic arthritis: warning on the use of sulfasalazine for a new indication
D Jullien, P Wolkenstein, E Roupie, et al.
Annales De Dermatologie Et De Venereologie
|
January 1, 1989
[Angiomatoid histiocytofibroma]
L Verne, T Clerici, J C Guillaume, et al.
Journal of the American Academy of Dermatology
|
April 1, 1992
Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus
P Saiag, E Caumes, O Chosidow, et al.
The British Journal of Dermatology
|
March 1, 1994
Increased serum and blister fluid levels of creatine kinase in patients with toxic epidermal necrolysis
F Caux, O Chosidow, C Philippon, et al.
Page
of 47